Association of Travel Burden with Definitive Prostate Cancer Treatment: A United States Registry Cohort Study
Authors:
- Filippo DagninoFDFilippo Dagnino
- Stephan KornSKStephan Korn
- Danesha DanielsDDDanesha Daniels
- Zhiyu QianZQZhiyu Qian
- Daniel StelzlDSDaniel Stelzl
- Hanna ZurlHZHanna Zurl
- Klara PohlKPKlara Pohl
- Mei-Chin HsiehMHMei-Chin Hsieh
- Brenda Y. HernandezBHBrenda Y. Hernandez
- Andrea PiccoliniAPAndrea Piccolini
- Giovanni LughezzaniGLGiovanni Lughezzani
- Nicolò M. BuffiNicolò M. Buffi
Preprint
Abstract
Purpose: Prostate cancer (PCa) mortality disparities are partly driven by unequal access to care. Transportation barriers may limit access to definitive treatment. We studied how driving travel time affects receipt of definitive PCa treatment. Materials and Methods: We conducted a cohort study of men with non-metastatic PCa (2000 - 2015; follow-up through 2018) across the metropolitan area cancer registries of seven US states. Travel burden was estimated using Google Maps isochrones representing driving time thresholds to reach the hospital appended to geomasked residential addresses. Outcomes were “no treatment, “ “radical surgery,” or “radiotherapy”. Covariate-adjusted multinomial logistic regression with interaction terms assessed modification by sociodemographic factors. Results: The study included 132,939 men, of whom 37.0% received no treatment, 41.0% underwent surgery, and 22.0% received radiotherapy. Longer driving time (≥90 min vs <30 min) was associated with higher radical prostatectomy (aOR: 1.07, 95% CI: 1.03, 1.12), but lower radiotherapy (0.72, 95% CI: 0.69 - 0.76). Subgroup analyses revealed higher surgery associated with longer driving times among those in nSES Q1 (aOR: 1.33, 95% CI: 1.21-1.45) vs Q5 (aOR: 0.94, 95% CI: 0.86-1.04), those in low (aOR: 1.16, 95% CI: 1.09-1.24) vs high (aOR: 1.03, 95% CI: 0.98-1.09) population density areas, and those with regional (aOR: 1.30, 95% CI: 1.14-1.48) vs localized (aOR: 1.05, 95% CI: 1.00 -1.09) disease. Longer driving time was mostly associated with lower odds of radiotherapy across sociodemographic subgroups. Conclusions: Higher travel burden was associated with lower radiotherapy receipt, but greater surgery use in deprived and rural patients, which warrants further investigation.Keywords
This publication has 26 references indexed in Scilit:
- Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate CancerJAMA Network Open, 2024
- Disparities in Travel-Related Barriers to Accessing Health Care From the 2017 National Household Travel SurveyJAMA Network Open, 2023
- Trends in mortality among Black and White men with prostate cancer in Massachusetts and Pennsylvania: Race and neighborhood socioeconomic positionCancer, 2021
- Access denied: The relationship between patient insurance status and access to high‐volume hospitalsCancer, 2020
- Equal access to health care reduces racial disparities in prostate cancer outcomesCancer, 2020
- Patterns in Geographic Access to Health Care Facilities Across Neighborhoods in the United States Based on Data From the National Establishment Time-Series Between 2000 and 2014JAMA Network Open, 2020
- Association of Care at Minority-Serving vs Non–Minority-Serving Hospitals With Use of Palliative Care Among Racial/Ethnic Minorities With Metastatic Cancer in the United StatesJAMA Network Open, 2019
- Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancerCancer, 2017
- Disparities in access to care at high‐volume institutions for uro‐oncologic proceduresCancer, 2012
- Neighborhood characteristics and hospital closuresSocial Science & Medicine, 1982